Neurogeneticists have discovered a novel genetic mutation and associated buildup of toxic proteins in the brain -- a type of buildup distinct from amyloid or tau, proteins that have long been the ...
News Medical on MSN9d
Breakthrough discovery on tau protein opens new paths for Alzheimer’s drug developmentA complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.
Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...
Enter SynPull, a new synaptosome imaging method developed by David Klenerman, John Danial, and colleagues at the University of Cambridge, England. SynPull combines single-molecule pull-down of ...
At the Human Amyloid Imaging (HAI) meeting, held January 15-17, researchers focused on new techniques—all based on tau and ...
The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of the puzzle.
The variant causes a person's brain to accumulate beta amyloid and phosphorylated tau proteins, the hallmarks of Alzheimer's. When Whitney turned 60 and still had no symptoms, he assumed he didn't ...
Scientists from Brigham and Women’s Hospital have now identified a new protein that may contribute to the disease.
“While most Alzheimer’s research has focused on the buildup of amyloid beta and tau, the polyGR proteins we’ve found ... through a patient’s entire human genome and grab a repeating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback